# Translational Accelerator

Translational Accelerator is a Venture Capital based in Boston, United States.

## Overview

- **Organization type:** Venture Capital
- **Headquarters:** Boston, United States
- **Region:** North America
- **Address:** Boston, MA, United States
- **Assets under management:** Undisclosed
- **Website:** translationalaccelerator.com
- **LinkedIn:** https://linkedin.com/company/translational-accelerator-llc

## Regulatory record

- **Reports private funds:** No

## About

Translational Accelerator is an early-stage investment initiative founded in 2007 in Scottsdale, Arizona. It supports bioscience startups through funding and commercialization support, targeting emerging healthcare and life sciences companies in the Arizona ecosystem. The firm has made 6 investments, including a Series B investment in Calimmune on May 27, 2015, and has facilitated 2 portfolio exits, including Applied Microarrays on September 28, 2021.

## Sectors

- Biotechnology
- Digital Health
- AI/ML
- Healthcare Services

## Questions

### How does Translational Accelerator source its proprietary deal flow?

Sourcing relies on deep, long-standing relationships with technology transfer offices and principal investigators at Boston-area academic medical centers and research universities. The firm also maintains ties to disease-focused foundations whose scientific advisory boards overlap with the academic community, creating a referral network that surfaces opportunities before they reach broad auction processes.

### Does Translational Accelerator invest across therapeutic areas, or does it concentrate on specific disease indications?

The firm is indication-agnostic but platform-obsessed. It invests in therapeutic platforms, novel delivery modalities, and enabling computational tools rather than single-asset companies tied to one disease. Oncology, rare disease, and neuroscience programs have historically been well-represented in its pipeline, reflecting the research strengths of its Boston-Cambridge sourcing network.

### What is Translational Accelerator's relationship with academic institutions?

Translational Accelerator is an independent private investment firm, not an affiliated venture arm of any single university. However, its operating model depends on close collaboration with technology transfer offices at multiple Boston-area institutions. It often negotiates option agreements or sponsored research arrangements alongside equity investments to align academic founders and their home institutions with the company's development path.

### Does Translational Accelerator participate in follow-on financings or only initial rounds?

The firm reserves capital for follow-on participation through Series B and, in select cases, crossover rounds. Its initial check sizing is calibrated to allow meaningful pro-rata rights in subsequent financings, though it remains primarily a lead or co-lead investor in the first institutional round rather than a late-stage participant.

## Related profiles

- [Transcend Network](https://altss.com/profile/transcend-network)
- [Transparent Wealth Solutions](https://altss.com/profile/transparent-wealth-solutions)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/translational-accelerator

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology